v3.25.0.1
Condensed Consolidated Statements of Changes in Convertible Preferred Stock and Stockholders' Equity/(Deficit) - USD ($)
$ in Thousands
Total
Common Stock [Member]
Preferred Stock [Member]
Convertible Preferred Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Beginning balance at Dec. 31, 2022 $ (44,368) $ 0 $ 118,024 $ 1,661 $ (45,868) $ (161)
Beginning balance, shares at Dec. 31, 2022   875,279 33,336,282      
Exercise of common stock options 5 $ 1   4    
Exercise of common stock options, shares   2,798        
Conversion of convertible preferred stock to common stock in connection with the Reverse Merger 118,024 $ 1 $ (118,024) 118,023    
Conversion of convertible preferred stock to common stock in connection with the Reverse Merger, shares   7,269,183 (33,336,282)      
Issuance of common stock and pre-funded warrants in the pre-closing financing, net of issuance costs 67,750     67,750    
Issuance of common stock and pre-funded warrants in connection with the private placement, net of issuance costs, shares   2,873,988        
Issuance of common stock value 71,825     71,825    
Issuance of common stock, shares   3,796,448        
Adjustment for change in common stock par value in connection with the Reverse Merger   $ 13   (13)    
Reverse recapitalization transaction costs (3,919)     (3,919)    
Stock-based compensation expense 2,900     2,900    
Net Income (Loss) (43,555)       (43,555)  
Unrealized gain on marketable securities 208         208
Ending balance at Dec. 31, 2023 168,870 $ 15 $ 0 258,231 (89,423) 47
Ending balance, shares at Dec. 31, 2023   14,817,696 0      
Exercise of common stock options $ 1,090     1,090    
Exercise of common stock options, shares 83,121 83,121        
Issuance of common stock and pre-funded warrants in the pre-closing financing, net of issuance costs $ 215,333 $ 14   215,319    
Issuance of common stock and pre-funded warrants in connection with the private placement, net of issuance costs, shares   14,500,500        
Exercise of pre-funded warrants   210,316        
Issuance of common stock value 39,200 $ 2   39,198    
Issuance of common stock, shares   1,503,708        
Stock-based compensation expense 12,894     12,894    
Net Income (Loss) (84,969)       (84,969)  
Unrealized gain on marketable securities 59         59
Ending balance at Dec. 31, 2024 $ 352,477 $ 31 $ 0 $ 526,732 $ (174,392) $ 106
Ending balance, shares at Dec. 31, 2024   31,115,341 0